Clinical Trials on Chronic Pelvic Inflammatory Disease in Japan

Total 874 results

Nagoya University
Japan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.

Completed

The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies (RECIPE)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Japan
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.

Chronic Inflammatory Demyelinating Polyneuropathy

Japan
Pfizer

Completed

Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan

Pelvic Inflammatory Disease

Japan
Pfizer

Completed

Xeljanz Special Investigation for Long-term Use in UC Patients

Ulcerative Colitis

Japan
Takeda

Active, not recruiting

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

Ulcerative Colitis

Japan
Kyoto University, Graduate School of Medicine
National Institute of Biomedical Innovation

Terminated

Therapeutic Study of ONO-4819CD for Ulcerative Colitis

Ulcerative Colitis

Japan
Pfizer

Completed

Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)

Crohn's Disease | Ulcerative Colitis

Japan
Kissei Pharmaceutical Co., Ltd.

Recruiting

An Early Phase 2 Clinical Study of KSP-0243

Colitis, Ulcerative

Japan
Takeda

Active, not recruiting

A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | Multifocal Motor Neuropathy (MMN)

Japan
Bayer

Completed

YAZ Post-marketing Surveillance in Japan

Dysmenorrhea

Japan
CSL Behring

Completed

Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

United States, Japan, Australia, Canada, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
Chikara Tashiro

Completed

Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA Screening

Inflammatory Bowel Disease | Pancreas Disease | Hepatobiliary Disease

Japan
Showa Inan General Hospital

Recruiting

Association Between LRG and Histologic Remission in Ulcerative Colitis

Ulcerative Colitis in Histologic Remission

Japan
Kyorin Pharmaceutical Co.,Ltd

Completed

Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA

Ulcerative Colitis

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis

Healthy Men and Subjects With Ulcerative Colitis

Japan
Takeda

Recruiting

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

Crohn's Disease

Japan
Bayer

Completed

Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in Japan

Dysmenorrhea

Japan
Eli Lilly and Company

Recruiting

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) (SHINE-ON)

Inflammatory Bowel Diseases | Crohn's Disease | Ulcerative Colitis | Ulcerative Colitis Chronic

United States, Japan, Korea, Republic of, Austria, Netherlands, Belgium, France, Poland, Spain, Italy, Germany
Keio University

Withdrawn

Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer

Peptic Ulcers

Japan
Astellas Pharma Inc

Completed

Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients

Ulcerative Colitis

Japan
Zeria Pharmaceutical

Completed

To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

Esophagitis, Reflux

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease

Crohn's Disease

Japan
Tokyo Medical and Dental University

Active, not recruiting

Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease

Crohn Disease

Japan
argenx

Active, not recruiting

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) (ADHERE+)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

United States, Austria, Belgium, Bulgaria, China, Czechia, Denmark, France, Georgia, Germany, Israel, Italy, Japan, Netherlands, Poland, Russian Federation, Serbia, Spain, Ukraine, United Kingdom, Latvia, Romania, Taiwan, Turkey
Takeda

Recruiting

A Survey of Darvadstrocel in People With Crohn's Disease (J-INSPIRE)

Crohn's Disease

Japan
Novo Nordisk A/S
Sponsor: Corvidia Therapeutics Inc, a subsidiary of Novo Nordisk A/S

Completed

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan. (RESCUE-2)

Inflammation | Chronic Kidney Disease | Cardiovascular Risk

Japan
argenx

Completed

A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) (ADHERE)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

United States, Austria, Belgium, Bulgaria, China, Czechia, Denmark, France, Georgia, Germany, Hungary, Israel, Italy, Japan, Latvia, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Taiwan, Turkey, Ukraine, United Kingdom
Bayer

Completed

Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea

Endometriosis and Dysmenorrhea

Japan
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis

Colitis, Ulcerative

Japan
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Pfizer

Completed

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

Arthritis, Rheumatoid | Psoriasis | Crohn Disease | Colitis, Ulcerative

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)

Crohn's Disease

Japan
Kanto CML Study Group

Unknown

Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan (D-First)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Myelogenous Leukemia, Chronic, Chronic Phase

Japan
Institute for Health Outcomes and Process Evaluation...

Completed

Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease (CAP-KD)

Kidney Failure, Chronic

Japan
University of Hyogo

Completed

Quantification of Autonomic Nervous Activity During Hemodialysis

Chronic Kidney Disease on Hemodialysis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis

Pediatric Ulcerative Colitis

Japan
Janssen Research & Development, LLC

Recruiting

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

United States, China, Taiwan, Korea, Republic of, Japan, France, Portugal, Spain, Czechia, Poland, Greece, United Kingdom
Osaka University

Active, not recruiting

Efficacy of Plant-protein Diets in Patients With Chronic Kidney Disease

Chronic Kidney Disease Stage 5

Japan
Yokohama City University Medical Center

Completed

Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease

Diabetes Mellitus | Renal Failure | Essential Hypertension | Chronic Nephropathy

Japan
Bayer

Completed

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea (J-MIRAI)

Menorrhagia, Dysmenorrhea

Japan
Pfizer

Completed

Safety And Efficacy Of Bosutinib (BLF)

Chronic Myelogenous Leukemia

Japan
Takeda

Completed

Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"

Reflux Esophagitis

Japan
Astellas Pharma Inc

Completed

Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis

Patients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis Therapy | Pharmacodynamics of ASP7991 | Pharmacokinetics of ASP7991

Japan
Iwata City Hospital
Hamamatsu University; University of Shizuoka

Completed

Relations Between Residual Renal Function and Oxidative and Carbonyl Stress in Peritoneal Dialysis Patients

Chronic Renal Failure

Japan
Novartis

Completed

Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients

Chronic Hepatitis C

Japan
Astellas Pharma Inc

Completed

Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients

Ulcerative Colitis

Japan
University of Shizuoka

Completed

The Effect of CoQ10 Administration on Hemodialysis Patients

Hemodialysis | Chronic Renal Failure

Japan
Bayer

Completed

A Study to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male Participants

Chronic Kidney Disease | Healthy Volunteers

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia

Chronic Kidney Disease Requiring Hemodialysis

Japan

Clinical Trials on Chronic Pelvic Inflammatory Disease in Japan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations